FDA would have to approve the trial including quality assurance. Most likely placebo or Rex would be sent to the participating doctors without label, so they may be biased, but they still don't know who is getting placebo. I can imagine a multi-center trial that could include some SurgCenter and some outside doctors. Just speculating...
Ann: Mesoblast Update on Chronic Low Back Pain Program, page-195
-
- There are more pages in this discussion • 146 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.000(0.00%) |
Mkt cap ! $1.147B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | $1.00 | $815.8K | 810.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 30792 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 67778 | 15 |
View Market Depth
| Last trade - 11.44am 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |